KindlyMD Shares Rocket 650% After Nakamoto Merger—Thanks to Bitcoin Treasury Gamble
Wall Street jaws hit the floor as KindlyMD—a healthcare player nobody had on their bingo card—became crypto’s latest moonshot. The trigger? A merger with Nakamoto and a full-throttle pivot to hodling Bitcoin on the balance sheet.
From stethoscopes to Satoshis
Analysts are scrambling to explain how a medical firm’s stock turned into a meme-worthy asset overnight. The answer: Nakamoto’s Bitcoin-heavy treasury strategy, which now has institutional investors FOMO-ing like retail traders during a bull run.
The cynical take
Because nothing screams ’stable growth’ like a healthcare company betting its future on volatile digital gold—just ask the bagholders of 2022’s crypto winter. But for now, the market’s voting with its wallet: straight to the moon.
David Bailey’s input
Bailey, a longtime Bitcoin advocate and advisor to Donald Trump’s 2024 campaign, will take the reins as CEO of the combined company. His goal: to build a new breed of financial institution that uses Bitcoin as a Core asset, akin to what Morgan or Rothschild once represented for fiat finance.
“Every balance sheet, public or private, will hold Bitcoin,” Bailey said in a statement. “We intend to be the first conglomerate designed for that world.”
The newly merged company aims to increase its Bitcoin holdings per share—what Bailey calls “Bitcoin Yield”—through future equity and debt offerings. The idea is to offer public investors a transparent, compliant structure to gain Bitcoin exposure without directly buying BTC.
While KindlyMD will continue operating its network of clinics focused on opioid reduction and alternative medicine, the merged entity’s real focus is financial.
The switch is backed by heavyweight crypto investors such as Adam Back, Balaji Srinivasan, and Jihan Wu.
The merger gives Bailey a Nasdaq-listed vehicle to package Bitcoin into equities, bonds, and hybrids for global exchange listings. The company will retain the KDLY ticker for now, with a new name and symbol expected following shareholder approval.
